Support Tasmania with telecare

NewsGuard 100/100 Score

On 30 April 2009, Tunstall Healthcare and Alzheimer's Australia Tasmania launched 'Telecare in Tasmania', a new respite facility fitted out with a range of Tunstall's assistive technologies, where people can come and try out the technology for themselves.

As well as providing telehealthcare products, Alzheimer's Australia Tasmania are offering a telecare library, where people can borrow the products to try before they buy or lease.

The Tunstall telecare products offered by Alzheimer's Australia Tasmania allows people living with dementia to remain living in the own home for longer.

This also provides people with greater independence while managing their illness.

Alzheimer's Australia Tasmania executive director, Debbie Slater believes the new project will offer great peace of mind for people living with dementia.

"Having a system like telecare will allow people living with dementia to feel safe and secure", Ms Slater said.

Chief executive officer of Alzheimer's Australia, Glenn Rees showed his supports for Tunstall and Alzheimer's Australia Tasmania's partnership by speaking at the launch.

"I am excited to be part of the launch and show my support for a technology that provides the chance at independence for people living with dementia or other disabilities", Mr Rees said.

To visit Alzheimer's Australia Tasmania new facility or borrow from the new telecare library call 03 6224 3077.

To find out more about Tunstall telecare call 1300 760 333 or visit www.tunstallhealthcare.com.au.

http://www.tunstallhealthcare.com.au

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Antipsychotics for dementia associated with elevated risks of serious adverse outcomes